CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE) [Phase 3]
Summary
Phase 3 trial update for afamelanotide in polymorphic light eruption has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Polymorphic Light Eruption | Phase 3 | Status: COMPLETED | Results posted: 2021-03-19